Results for fibroids translation from English to Maltese

fibroids inside your womb
fibrojdi fl-utru

fibroids in the womb (uterus)
fibrojdi fil-ġuf (utru)

leiomyoma (uterine fibroids) or endometriosis
leijomijoma (fibrojdi fl- utru) jew endometrijosi •

if you have fibroids in the uterus which make a normal pregnancy impossible
jekk għandek il- fibrojdi fl- utru li jagħmel tqala normali impossibli

genital bleeding of unknown aetiology or for reasons other than uterine fibroids.
fsada ġenitali li r-raġuni tagħha ma tkunx magħrufa jew għal raġunijiet oħra għajr il-fibrojdi fl-utru.

ovaries which have not developed properly, fibroids) or you have been through menopause
- għandek xi kundizzjoni li minħabba fiha tqala normali mhix possibbli (eż. nuqqas ta ’ utru,

the size of the fibroids was also smaller in women treated with esmya than in those who received the placebo.
id-daqs tal- fibrojdi kien ukoll iżgħar fin-nisa li kienu rċevew kura b’esmya minn ta’ dawk li kienu rċevew il- plaċebo.

the main measures of effectiveness were reductions in heavy bleeding and associated anaemia, as well as the size of the fibroids.
il-kejl ewlieni tal-effikaċja kien it-tnaqqis fit-tnixxija qawwija ta’ demm u l-anemija assoċjata, kif ukoll id-daqs tal-fibrojdi.

esmya has been investigated in two main studies involving 549 women with symptomatic uterine fibroids who were to undergo surgery to remove the fibroids.
esmya kien investigat f'żewġ studji ewlenin li kienu jinvolvu 549 mara b'fibrojdi sintomatiċi fl-utru li kellu jkollhom intervent kirurġiku biex jitneħħew il-fibrojdi.

based on pooled data from four phase iii studies in patients with uterine fibroids treated for 3 months, the following adverse reactions have been reported.
abbażi tat-tagħrif miġbur minn erba’ studji tal-fażi iii fuq pazjenti bil-fibrojdi fl-utru li rċevew kura għal 3 xhur, ġew irrappurtati r-reazzjonijiet avversi li ġejjin.

the chmp considered that esmya was shown to be effective in reducing bleeding and anaemia as well as the size of the fibroids in women who were to undergo surgery for their fibroids.
is-chmp qies li esmya intwera li kien effettiv fit-tnaqqis tat- tnixxija tad-demm u tal-anemija kif ukoll fid-daqs tal-fibrojdi f'nisa li kellu jkollhom intervent kirurġiku għall-fibrojdi tagħhom.

it is used either before an operation of your fibroids or for long term treatment of your fibroids to reduce their size, to stop or reduce bleeding and to increase your red blood cell count.
tintuża qabel operazzjoni tal-fibrojdi tiegħek jew għal kura fit-tul tal-fibrojdi tiegħek sabiex tnaqqas id-daqs tagħhom, sabiex twaqqaf jew tnaqqas il-fsada u sabiex iżżid l-għadd ta’ ċelloli ħomor tad-demm tiegħek.

long-term treatment with esmya has been investigated in a main study involving 451 women with symptomatic uterine fibroids who were given 4 three-month courses of esmya.
il-kura fit-tul b'esmya kienet investigata fi studju ewlieni li kien jinvolvi 451 mara b'fibjojdi sintomatiċi fl-utru li ngħataw 4 korsijiet ta' tliet xhur ta' esmya.

the efficacy of repeated treatment courses fixed doses of ulipristal acetate 5 mg or 10 mg once daily was evaluated in two phase 3 studies assessing up to 4 intermittent 3-month treatment courses in patients with heavy menstrual bleeding associated with uterine fibroids.
l-effikaċja ta’ dożi fissi b’korsijiet ta’ kura ripetuti ta’ ulipristal acetate 5 mg jew 10 mg darba kuljum kienet evalwata f’żewġ studji tal-fażi 3 li jivvalutaw sa 4 korsijiet ta’ kura intermittenti ta’ 3 xhur f’pazjenti bi fsada mestrwali qawwija assoċjata ma’ fibrojdi fl-utru.

the efficacy of fixed doses of ulipristal acetate 5 mg and 10 mg once daily was evaluated in two phase 3 randomised, double-blind, 13 week studies recruiting patients with very heavy menstrual bleeding associated with uterine fibroids.
l-effikaċja ta’ dożi fissi ta’ ulipristal acetate ta’ 5 mg u ta’ 10 mg darba kuljum ġiet evalwata f’żewġ studji double blind, randomised, tal-fażi 3, li damu għaddejjin 13-il ġimgħa li fihom ħadu sehem pazjenti li kellhom tnixxija mestrwali qawwija ħafna assoċjata mal-fibrojdi fl-utru.

37 • ovarian cysts or enlarged ovaries, not related to polycystic ovarian disease (pcod). • malformations of the sexual organs incompatible with pregnancy. • fibroid tumours of the uterus incompatible with pregnancy. • primary testicular failure.
38 • tumuri ta ’ l- ovarju, tas- sider, ta ’ l- utru, tat- testikoli, tal- pitwitarju jew ta ’ l- ipotalamu. • emorraġija vaġinali li ma nstabx x’ qed jikkawżha. • indeboliment primarju ta ’ l- ovarji. • Ċisti fl- ovarji jew ovarji mkabbra, mhux relatati mal- mard poliċistiku ta ’ l- ovarji (pcod). • malformazzjonijiet ta ’ l- organi sesswali li huma inkompattibli mat- tqala. • tumuri fibrojdi ta ’ l- utru li huma inkompattibli mat- tqala. • indeboliment primarju tat- testikoli.